- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Ulcerative colitis
- Meeting Date: November 2022
- Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 391KB)
Ozanimod – November 2022
Ozanimod: Capsule 920 micrograms, Pack containing 4 capsules 230 micrograms and 3 capsules 460 micrograms: Zeposia®
Last updated
3 March 2023